Centre Hospitalier Intercommunal De Poissy Saint Germain

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Multiple sclerosis2 trials
• Follicular lymphoma1 trial
• Neuromyelitis optica (NMOSD)1 trial

Phase

• Phase 32 trials
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Not yet recruiting1 trial

Lead sponsor

• Lysarc1 trial
• Rennes University Hospital1 trial
• University Hospital, Toulouse1 trial

Running trials

• Not yet recruiting

  Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial

  NCT07818356· Phase 4· University Hospital, Toulouse· Source

• Active, not recruiting

  MorningLyte: Evaluation of the benefits of the combination of mosunetuzumab plus lenalidomide versus a treatment with anti-CD20 monoclonal antibody plus chemotherapy in subjects with previously untreated FLIPI 2-5 follicular lymphoma

  2023-505436-35-00· Phase 3· Lysarc· Source

• Active, not recruiting

  Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years (STOP-I-SEP)

  NCT03653273· Phase 3· Rennes University Hospital· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple sclerosis1 recruiting
• Neuromyelitis optica (NMOSD)1 recruiting